No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease - Concepedia

Concepedia

Publication | Open Access

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

DOI Full Paper Access

131

Citations

27

References

2016

Year

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green, Annette Marcantonio, Tsung‐Teh Wu, Markku Mäki, Daniel C. Adelman, Shoab Ansari, K Ayub, Anna Basile,

Gastroenterology

Difference Between LatiglutenaseVillous AtrophyClinical PresentationCeliac DiseaseMedicineSymptomatic Celiac Disease

References

	Year	Citations

Page 1